DEFM14A: CompoSecure to Acquire Husky Technologies in $3.95B Deal

CompoSecure, Inc. seeks stockholder approval for a strategic combination with Husky Technologies Limited, valued at approximately $3.953 billion in cash and 55.3 million shares of CompoSecure common stock.

Summary

• CompoSecure, Inc. (CMPO) and certain subsidiaries entered into a Share Purchase Agreement with Husky Technologies Limited (Husky) and its sellers on November 2, 2025.
• The aggregate consideration for Husky is approximately $3.953 billion in cash and 55,297,297 shares of CompoSecure Class A Common Stock.
• Following the closing, Husky will become an indirect wholly-owned subsidiary of CompoSecure.
• Concurrently, CompoSecure entered into Purchase Agreements with institutional investors for a private placement (PIPE) of approximately 106,057,000 shares of CompoSecure Common Stock at $18.50 per share, raising approximately $1.96 billion.
• CompoSecure also secured debt commitments for a senior secured first lien term loan facility of $725 million and an incremental term loan facility of $350 million to help finance the cash consideration and refinance existing debt.
• Stockholder approval is required for the issuance of CompoSecure Common Stock, as it represents more than 20% of the voting power or number of shares outstanding before the issuance, as per NYSE rules.
• Existing CompoSecure stockholders are estimated to own approximately 45% of the combined company, sellers will own approximately 19%, and PIPE investors will own approximately 36% immediately following the closing.
• The Board of Directors unanimously recommends a vote FOR the Stock Issuance Proposal, deeming the transaction fair and in the best interests of CompoSecure and its stockholders.
• Morgan Stanley & Co. LLC provided an oral fairness opinion on November 1, 2025, confirmed in writing on November 2, 2025, stating the aggregate consideration is fair from a financial point of view to CompoSecure.

Sentiment

Score: 8

Explanation: The filing presents a strong positive outlook on the strategic merger, emphasizing accretion, scale, diversification, and financial advisor support. While risks are disclosed, they are framed as manageable or inherent to such large transactions, leading to an overall highly positive sentiment.

Positives

• The transaction is expected to be immediately accretive to key fiscal year 2026 estimated financial metrics, including at least 20% accretive to adjusted diluted earnings per share in the first full year post-closing.
• Increased scale and financial strength are anticipated to enable meaningful cost optimizations, broaden institutional investor participation, improve trading liquidity, and increase analyst coverage.
• The combination with Husky provides substantial revenue, customer, and end-market diversification, mitigating long-term tail risks associated with CompoSecure's current business.
• The merger consideration mix balances liquidity and cash flow risks, pro forma indebtedness, and current stockholder ownership percentage dilution, benefiting CompoSecure and its stockholders.
• The number of CompoSecure Common Stock shares issued to Husky equityholders is fixed, subject to limited exceptions, and will not fluctuate with market price decreases.
• Morgan Stanley's fairness opinion supports the financial terms of the transaction from CompoSecure's perspective.
• The terms of the Transaction Agreement are considered reasonable and appropriate, including the Board's ability to change its recommendation in response to certain intervening events and limited termination circumstances.
• The right for Platinum to nominate two directors to the Board post-closing is commensurate with its pro-forma ownership and is expected to add expertise and experience.
• Resolute's approval of the transaction documents and transactions was considered a positive factor.

Negatives

• The significant portion of the transaction consideration consisting of CompoSecure Common Stock will result in substantial dilution of existing CompoSecure stockholders' ownership percentage.
• The cash consideration is partly funded through a private placement, leading to further dilution for current stockholders.
• Restrictions on the conduct of CompoSecure's business between the Agreement Date and Closing Date, requiring operations to be in the ordinary course subject to specific exceptions, may limit flexibility.
• The transaction involves substantial non-recurring costs, including financial advisory, legal, financing, and accounting fees, which will be borne by CompoSecure even if the transaction is not completed.
• Platinum will have certain governance rights post-closing, including the right to nominate directors, which could influence CompoSecure's business and potentially conflict with other stockholders' interests.
• The Cash Consideration is subject to adjustments, meaning the final amount paid may be higher than the base $3.953 billion, potentially reducing the value of the transaction to CompoSecure and its current stockholders.
• The unaudited pro forma financial statements are for illustrative purposes only and may not represent the actual financial position or results of the combined company, with actual results potentially differing materially.
• The opinion of CompoSecure's financial advisor does not reflect changes in circumstances between the signing of the Transaction Agreement and the Closing Date, and may not reflect the fairness of the consideration at closing.
• The company may be subject to litigation challenging the transactions, which could result in substantial costs and divert management resources, or even prevent or delay the consummation of the transactions.

Risks

• The transactions may not be completed on anticipated terms and timing or at all, due to risks associated with obtaining stockholder approval, regulatory clearances, and satisfying other closing conditions.
• The occurrence of any event, change, or other circumstance could give rise to the termination of the Transaction Agreement.
• Unforeseen or unknown liabilities, future capital expenditures, and potential litigation relating to the transactions.
• The possibility that the transactions may be more expensive to complete than anticipated, including unexpected factors or events.
• The announcement, pendency, or completion of the transactions may adversely affect CompoSecure's or Husky's business relationships and general business operations.
• Risks that the transactions disrupt CompoSecure's current plans and operations or those of its management team.
• Potential difficulties in retaining employees as a result of the transactions.
• Risks related to CompoSecure's financing of the transaction, including debt financing and the private placement.
• Potential negative effects of the announcement, pendency, or completion of the transactions on the market price of CompoSecure Common Stock and/or CompoSecure's operating results.
• CompoSecure and Husky being restricted in the operation of their respective businesses while the Transaction Agreement is in effect.
• The dilution of CompoSecure Stockholders' ownership percentage of the combined company compared to their ownership percentage prior to the transactions.
• The possibility that CompoSecure's results of operations, cash flows, and financial position after the transactions may differ materially from the unaudited pro forma condensed consolidated financial information or prospective financial information.
• The uncertainty surrounding the final value of the consideration to be paid by CompoSecure in connection with the transactions.
• Risks associated with the influence of Platinum over the management and board of CompoSecure following the transactions.
• Risk of rapidly evolving domestic and global economic conditions, which are beyond control.
• CompoSecure's ability to retain existing customers or identify and attract new customers.
• Risks that data and security breaches could compromise systems and confidential information, cause reputational and financial damage, and increase litigation risks.
• Risk of system outages, data loss, or other interruptions affecting operations.
• Future growth may depend on the ability to develop and commercialize new products, with potential difficulties or delays in timely introduction.
• Risk of disruptions in the supply chain or the performance of suppliers and/or development partners.
• Risks related to the rapid evolution of security markets, including that Arculus Authenticate solutions may not achieve widespread market acceptance or provide sufficient protection.
• Limited experience in the digital assets industry and potential failure to fully commercialize products and solutions derived from Arculus technology.
• Risks relating to dependence on certain distribution partners and the risk of their loss.
• Risks to market share and profitability due to competition.
• Risks relating to the management of the business by Resolute Holdings, including reliance on Resolute Holdings for management services, giving it substantial influence.
• Uncertainty surrounding escalating U.S. tariffs or other trade restrictions on imported raw materials, and any retaliatory measures by other countries, could increase costs or impact demand.
• Changes in future exchange and interest rates.
• Husky's results of operations are reliant on unpredictable customer purchasing trends and the timing of converting orders into sales, leading to variations and uncertainties.
• Growth in emerging markets may impact Husky's sales if urbanization and middle-class growth slow or alter significantly.
• No certainty that Husky will be able to manage fluctuations in raw materials, particularly tooling stainless steel, which could impact results of operations.
• Failure of suppliers to deliver in a timely and cost-effective manner would adversely impact Husky's operations, including supply chain disruptions and inflationary cost increases.
• Husky is subject to U.S. and certain foreign export and import controls, sanctions, embargoes, anti-corruption laws, and anti-money laundering laws and regulations, with potential serious consequences for violations.
• Husky may face exposure to adverse movements in foreign currency exchange rates, particularly between the Canadian dollar and U.S. dollar/Euro.
• Changes in U.S. trade policies, including tariffs, could adversely affect Husky's business, financial condition, or results of operations.
• Husky's significant international operations subject it to risks inherent in doing business in foreign jurisdictions, such as unfavorable political, regulatory, economic, labor, and tax conditions.
• Husky may be unable to attract or retain key employees during the pendency of the transactions due to uncertainty.
• If Husky is unable to continue technological innovation and successful introduction of new products, customers may delay orders or turn to competitors.
• If the use of plastic as a packaging material declines due to perception of recyclability, environmental impact, health concerns, or competitive materials, it could materially adversely affect Husky's business.
• If Husky's products fail to perform or meet customer requirements, significant additional costs could be incurred, including warranty expenses or product liability lawsuits.
• New or increased taxes or other governmental regulations targeted to decrease consumption of certain beverages may adversely affect Husky's business by reducing demand for its products.
• Husky's patents may not prevent competitors from making and selling similar products, and enforcing intellectual property rights can be costly and time-consuming.
• Competitors may misappropriate Husky's trade secrets or infringe its intellectual property, and Husky may not be able to stop them.
• Cybersecurity risks, including technology failures or cyber-attacks, could disrupt Husky's operations, harm its reputation, and negatively impact business and customer relationships.
• Some of Husky's customers have been sued for patent infringement related to products made using Husky molds, and Husky could face similar lawsuits or customer demands for indemnification.
• Unanticipated changes in tax provisions, variability of quarterly and annual effective tax rates, new tax legislation, or exposure to additional tax liabilities could impact Husky's financial performance.
• Husky is exposed to interest rate risk through its long-term floating rate debt and credit risk from financial assets, which could be impacted by changes in counterparties' financial condition.

Future Outlook

CompoSecure anticipates completing the transactions in the first quarter of 2026, subject to satisfaction or waiver of closing conditions. The transactions are expected to be immediately accretive to key fiscal year 2026 estimated financial metrics, including at least 20% accretion to adjusted diluted earnings per share in the first full year post-closing. The combined company aims for increased scale, financial strength, and revenue/customer/end-market diversification.

Management Comments

• David M. Cote, Executive Chairman of the Board, and Jonathan C. Wilk, President, Chief Executive Officer and Director, expressed appreciation for stockholder support and interest, looking forward to the success of the transactions.
• The Board of Directors determined that the Transaction Agreement and related transactions are fair to and in the best interests of CompoSecure and its stockholders, and resolved to recommend stockholder approval of the Stock Issuance.

Industry Context

CompoSecure, a technology partner specializing in metal payment card technology and Arculus security solutions, is combining with Husky Technologies, a global provider of highly engineered injection molding technology solutions and services for consumer packaging. This merger significantly diversifies CompoSecure's business into a different end-market, moving beyond its current focus on payment cards and digital security to include industrial equipment and aftermarket services for plastic packaging, medical devices, and consumer electronics. This strategic move aims to mitigate long-term risks associated with CompoSecure's existing business by broadening its revenue, customer base, and end-market exposure.

Comparison to Industry Standards

• Morgan Stanley's comparable company analysis for Husky reviewed publicly traded companies in the industrial equipment, machinery, and engineered-systems sectors, including Nordson Corporation, Lincoln Electric Holdings, Inc., Donaldson Company, Inc., ESAB Corporation, Sealed Air Corporation, JBT Marel Corporation, Hillenbrand Inc., GEA Group AG, and Krones AG.
• Median AV/EBITDA multiples observed were approximately 14.4x for calendar year 2025 and 12.8x for calendar year 2026 across Husky's primary peer set.
• Morgan Stanley's selected precedent transactions analysis reviewed transactions since 2017, observing a median AV/LTM EBITDA multiple of 13.5x for target companies in similar industries.

Management Changes

Corporate Governance

Legal Proceedings

• Securities class action lawsuits and derivative lawsuits are often brought against publicly listed companies that have entered into acquisition agreements, and defending against these claims can result in substantial costs and divert management time and resources.
• An adverse judgment in such lawsuits could result in monetary damages, which could have a negative impact on CompoSecure.
• If a plaintiff is successful in obtaining an injunction prohibiting completion of the transactions, it may delay or prevent the transactions from being completed, adversely affecting CompoSecure's business.
• Husky has been named as defendant in certain legal actions and is subject to various risks and contingencies arising in the ordinary course of business, including product liability, environmental matters, health and safety, and personal injury matters.
• Some of Husky's customers have been sued for patent infringement in connection with products made using molds purchased from Husky, and Husky could face similar lawsuits or demands for indemnification.

Related Party Transactions

• The PE Sellers are entities affiliated with Platinum Equity Advisors, LLC, which will nominate two directors to CompoSecure's board post-closing and will have certain governance and information rights.
• Resolute Compo Holdings LLC, Tungsten 2024 LLC, and Ridge Valley LLC (Voting Stockholders), whose managers include CompoSecure directors John D. Cote and Thomas R. Knott, have agreed to vote their shares in favor of the Stock Issuance Proposal.
• John D. Cote, a CompoSecure director, is the manager of Tungsten and Ridge Valley LLC.
• Thomas R. Knott, a CompoSecure director, is the sole managing member of C 323 Holdings, LLC, a non-managing member of Resolute Compo Holdings.
• Certain CompoSecure directors and their affiliates, including members of their immediate family, intend to participate in the Private Placement, acquiring approximately 957,000 PIPE Shares, which was approved by the Audit Committee.
• Following the closing, Forge Holdings (holding Husky's business) will enter into a Management Agreement with Resolute Holdings Management, Inc., under which Resolute Holdings will provide management services for quarterly fees. This may benefit CompoSecure directors associated with Resolute Holdings.
• Husky has a promissory note receivable of $20.0 million from an entity with a majority ownership in Husky, bearing 6% interest and due on demand, as of September 30, 2025.
• Husky has other receivables of $1.8 million from its parent holding companies related to general and administration fees paid on their behalf, as of September 30, 2025.
• Husky incurred costs of $5.7 million, $5.6 million, and $5.2 million in 2024, 2023, and 2022, respectively, for corporate and advisory services from Platinum Equity Advisors, LLC.
• Husky has business relationships with Data2Logistics, LLC (D2L), Livingston International Inc. (Livingston), and The HC Companies, Inc. (HC), which are or were affiliated with Platinum, incurring costs for services and having sales to HC.

Stakeholder Impact

• Shareholders: Existing CompoSecure stockholders will experience significant dilution of their ownership percentage (expected to be ~45% post-merger) due to the issuance of new shares to sellers and PIPE investors. However, they are expected to benefit from the transaction's accretive nature, increased scale, and diversification.
• Employees: Uncertainty about future roles may affect retention of key managers and other employees at both CompoSecure and Husky. CompoSecure has committed to providing continuing employees with comparable base salary, wages, and annual target cash incentive compensation opportunities, and substantially similar aggregate benefits for at least one year post-closing.
• Customers: Uncertainty regarding the completion of the transactions may cause commercial and vendor partners to delay or defer business decisions or seek to terminate/renegotiate relationships, potentially affecting revenues and cash flows.
• Management: Management attention may be diverted towards completing the transactions. Post-closing, Platinum will have influence over the board, and Resolute Holdings will manage Husky's day-to-day operations for a fee, potentially increasing management fees for individuals associated with Resolute Holdings.
• Creditors: The transaction involves significant debt financing and refinancing of existing indebtedness, which will alter the combined company's capital structure and may subject CompoSecure to new covenants.

Next Steps

• CompoSecure stockholders will vote on the Stock Issuance Proposal at a special meeting on December 23, 2025.
• The parties will continue to work towards satisfying closing conditions, including regulatory approvals under the HSR Act and other applicable Antitrust and FDI Laws.
• CompoSecure will prepare and file a proxy statement with the SEC and mail it to stockholders.
• CompoSecure will arrange and obtain the Backstop Debt Financing and ensure definitive agreements are in place by the Closing Date.
• The Company will purchase directors and officers and fiduciary liability run-off/tail insurance coverage prior to the Closing Date.
• CompoSecure will take actions to cause two additional directors nominated by Platinum to be appointed to the Board immediately following the Closing.
• The parties will cooperate in preparing and filing Tax Returns and addressing Tax matters.

Key Dates

Recommendation

The proposed merger with Husky Technologies is strategically sound, offering significant benefits that outweigh the identified risks. The transaction is expected to be immediately accretive to adjusted diluted EPS by at least 20% in the first full year post-closing, indicating strong financial upside. The substantial increase in scale and financial strength, coupled with significant revenue, customer, and end-market diversification, mitigates long-term business risks and enhances the company's competitive position. While dilution for existing shareholders is a factor, the fixed stock consideration for sellers and the overall accretive nature of the deal suggest a favorable return on investment. The Board's unanimous recommendation and Morgan Stanley's fairness opinion further bolster confidence in the transaction's value proposition. The debt financing and private placement are secured, ensuring funding for the cash component. Despite potential integration challenges and market uncertainties, the strategic rationale and expected financial performance make this a compelling 'buy' opportunity for long-term investors.

Keywords

CompoSecure, Husky Technologies, Merger, Acquisition, SEC Filing, DEFM14A, Proxy Statement, Stock Issuance, Private Placement, PIPE Investment, Financial Reporting, Corporate Governance, Risk Management, Metal Payment Cards, Arculus Security, Injection Molding, PET Systems, Manufacturing, Financial Analyst, Investment, Shareholder Approval, NYSE Listing, Dilution, Regulatory Approvals, Debt Financing, Platinum Equity